1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Clinical Trial Design for Commercial Success

Clinical Trial Design for Commercial Success

  • June 2015
  • -
  • Firstword Pharma
  • -
  • 72 pages




Clinical Trial Design for Commercial Success offers expert insights on how to best position drugs for success through strategic innovative design of clinical trials.

Clinical trials make up, on average, nearly 60 percent of the total development costs for a new drug, and marketplace success is by no means guaranteed. In this challenging environment, complacency in trial design and execution carries a heavy cost.

From launch to patent expiry, Clinical Trial Design for Commercial Success offers key insights on building clinical trials that give new drugs every advantage in the marketplace.









Top Benefits



Learn how strategic design of clinical trials can drive the commercial success of new therapies
Understand how to ‘design-in’ value creation so your clinical trial delivers data that influences payers and prescribers
Learn how to keep your clinical trials on track for commercial success from day one



Answers to Critical Questions

How can companies meet the need to deliver returns over the short- and long-term through the design and implementation of clinical trials?
Where and when does the process of designing clinical trials for commercial success start? Who are the key stakeholders that need be involved?
To what extent should commercial factors like pricing, branding, positioning and risk-benefit be factored into clinical development?
How do alternative trial designs and the generation of real-world data contribute to commercial success?



Experts Interviewed

Manolo Beelke, Senior Medical Director, Worldwide Clinical Trials
Cecil Nick, Vice President, Biotechnology, Parexel Consulting
Bob Swann, hHad of US P&MA, Heron Commercialization (Parexel)
Rick Sax, Senior Vice President, Clinical Design & Reporting Services, Quintiles
Dr Michael Kirchengast, Senior Vice President, Scientific Affairs, PRA Health Sciences
Leo James, Associate Director, Medical Affairs - Clinical Trials, Astellas Pharma
Dr Domenico Merante, Senior Director Clinical Development, Daiichi Sankyo, UK




About FirstWord Reports

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence



FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.


Table Of Contents

Clinical Trial Design for Commercial Success
1.Research Objective and Methodology
2.New models for commercial success
2.1.Success in the post-blockbuster era
2.2.Choosing a commercial model
2.3.The therapy area counts
… and the stage of development
2.1.Addressing unmet need
2.2.Industry is behind the curve
2.3. Cost-effective trials
3.The right compound for success
3.1. Determining commercial viability
4. A herd mentality in RandD?
5. Planning for commercial success
6.Integrated asset development
6.1.Ensure you have a solid evidence plan
7.Accommodating divergent stakeholder needs
8.The cross-functional team
9.Breaking down internal silos
10.Incentives for success
11.Value of external input into trial design
11.1 Addressing payer needs
12.Talking to everyone about trial design
12.1. Where to look for clinical-trial input
12.2. Cultivating key opinion leaders
13. Learning from patients
13.1.Patient input and corporate branding
14. Commercial endpoints and populations
15.Patient-relevant outcomes
16.Benefit versus risk
17.Comparative effectiveness
18.Patient segmentation
19.Commercially oriented trial designs
19.1. Adaptive Trials
20.Conclusions

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
HPLC Markets: Global Analysis and Opportunity Evaluation 2016 - 2020

HPLC Markets: Global Analysis and Opportunity Evaluation 2016 - 2020

  • $ 5800
  • Industry report
  • October 2016
  • by Laboratory Markets Limited

This market report provides a comprehensive and easy-to-review analysis of the analytical HPLC market 2016 to 2020, providing key market data and identifying new and emerging opportunities across this ...

Label-free Array Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Label-free Array Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Global Label-free Array Systems: Overview Label-free array systems are used in the drug discovery industry by pharmaceutical and biotechnology companies, and work on the principles of optical interferometry, ...

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global bioinformatics market is projected to reach USD 16.18 billion by 2021 from USD 6.21 billion in 2016, growing at a CAGR of 21.1% during the forecast period. In this report, the bioinformatics ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.